TEK Antikörper
Kurzübersicht für TEK Antikörper (ABIN1589890)
Target
Alle TEK Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- Rabbit Anti-Human TIE-2 Polyclonal Antibody
-
Spezifität
- Recombinant human sTIE-2
-
Produktmerkmale
- Chromosomal location: 9p21
-
Aufreinigung
- Protein A purified
-
Immunogen
- Recombinant human sTIE-2 ( (ABIN1589753)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Western Blot: Use 2-5 μg/mL
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Centrifuge vial prior to opening. Reconstitute in sterile water to a concentration of 0.1-1.0 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Centrifuge vial prior to opening.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- The lyophilized antibody is stable for at least 2 years at -20°C. After sterile reconstitution the antibody is stable at 2-8°C for up to 6 months. Frozen aliquots are stable for at least 6 months when stored at -20°C. Addition of a carrier protein or 50% glycerol is recommended for frozen aliquots.
-
Haltbarkeit
- 24 months
-
-
- TEK (TEK Tyrosine Kinase, Endothelial (TEK))
-
Andere Bezeichnung
- TIE-2
-
Hintergrund
-
Synonyms: TEK, TIE2, VMCM, TIE-2, VMCM1, CD202B
Description: TIE-1 (tyrosine kinase with Ig and EGF homology domains 1) and TIE-2/TEK comprise a receptor tyrosine kinase (RTK) subfamily with unique structural characteristics: two immunoglobulin-like domains flanking three epidermal growth factor (EGF)-like domains and followed by three fibronectin type III-like repeats in the extracellular region and a split tyrosine kinase domain in the cytoplasmic region. These receptors are expressed primarily on endothelial and hematopoietic progenitor cells and play critical roles in angiogenesis, vasculogenesis and hematopoiesis. Human TIE-2 cDNA encodes a 1124 amino acid (aa) residue precursor protein with an 18 residue putative signal peptide, a 727 residue extracellular domain and a 354 residue cytoplasmic domain. Two ligands, angiopoietin-1 (Ang1) and angiopoietin-2 (Ang2), which bind TIE-2 with high affinity have been identified. Ang2 has been reported to act as an antagonist for Ang1. Mice engineered to overexpress Ang2 or to lack Ang1 or TIE-2 display similar angiogenic defects.
-
Gen-ID
- 7010
-
NCBI Accession
- NM_000459, NP_000450
-
UniProt
- Q02763
-
Pathways
- RTK Signalweg, Growth Factor Binding
Target
-